Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.190
-0.110 (-2.56%)
At close: Jul 2, 2026, 4:00 PM EDT
4.140
-0.050 (-1.19%)
After-hours: Jul 2, 2026, 5:27 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $225.35 million as of July 2, 2026. Its market cap has increased by 137.99% in one year.
Market Cap
225.35M
Enterprise Value
102.31M
1-Year Change
137.99%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $225.35M, a decrease of -58.33%. That is a compound annual growth rate of -16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 225.35M | 97.59% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 230.38M |
| Camp4 Therapeutics | 230.03M |
| Alector | 228.71M |
| Voyager Therapeutics | 228.39M |
| Protara Therapeutics | 228.19M |
| NervGen Pharma | 225.15M |
| Codexis | 224.51M |
| Coherus Oncology | 223.66M |